The expression level of the telomerase catalytic subunit (telomerase reverse transcriptase, TERT) positively correlates with cell survival after exposure to several lethal stresses. However, whether the protective role of TERT is independent of telomerase activity has not yet been clearly explored. Here, we genetically evaluated the protective roles of both TERT and telomerase activity against cell death induced by staurosporine (STS) and N-methyl-Daspartic acid (NMDA). First generation (G1) TERTdeficient mouse embryonic fibroblasts (MEFs) displayed an increased sensitivity to STS, while TERT transgenic MEFs were more resistant to STS-induced apoptosis than wildtype. Deletion of the telomerase RNA component (TERC) failed to alter the sensitivity of TERT transgenic MEFs to STS treatment. Similarly, NMDA-induced excitotoxic cell death of primary neurons was suppressed by TERT, but not by TERC both in vitro and in vivo. Specifically, NMDA accelerated death of TERT-deficient mice, while TERT transgenic mice showed enhanced survival when compared with wild-type littermates after administration of NMDA. In addition, the transgenic expression of TERT protected motor neurons from apoptosis induced by sciatic nerve axotomy. These results indicate that telomerase activity is not essential for the protective function of TERT. This telomerase activity-independent TERT function may contribute to cancer development and aging independently of telomere lengthening.
The telomerase reverse transcriptase (TERT) subunit and the telomerase RNA component (TERC) constitute the minimally active telomerase (Blackburn, 2001) , and several other proteins have been shown to associate with these subunits (McEachern et al., 2000; Blackburn, 2001) . Telomerase maintains telomeres and thus promotes the maintenance of genomic integrity by protecting chromosomes from end-to-end fusion, aneuploidy, degradation and aberrant recombination (Blasco et al., 1997; Lee et al., 1998) .
DNA polymerases are unable to replicate the ends of linear DNA (Shay et al., 2001) . Thus, in human cells in which TERT expression is repressed, telomere erosion occurs with successive cell divisions and ultimately induces replicative senescence (Shay et al., 2001) . In contrast, most cancer cell lines manifest a high level of telomerase activity and constitutively overexpress TERT (Kim et al., 1994) . Overexpression of TERT in cells that lack telomerase activity induces constitutive telomerase activity and contributes to immortalization (Nakayama et al., 1998; Morales et al., 1999) . Inhibition of telomerase activity induces telomere shortening, genomic instability and apoptosis in tumor cells (Hahn et al., 1999) . Consistent with these observations, overexpression of TERT contributes to tumorigenesis in both human and murine models of transformation (Blasco et al., 1997; Hahn et al., 1999; Artandi et al., 2002) .
Beyond the clear role of telomerase in maintaining telomere length, several lines of evidence suggest that TERT has additional physiological functions (Chung et al., 2005) . For example, it has been reported that telomerase expression confers increased resistance and cell survival to agents that induce cellular stress (Sung et al., 2005) . We have also reported that transgenic mice overexpressing murine TERT (mTERT) manifest significant resistance to ischemic brain injury and N-methyl-D-aspartic acid (NMDA) receptormediated excitotoxicity (Kang et al., 2004) . More recently, two groups have shown that transgenic mice that overexpress TERT in the skin show altered hair follicle dynamics (Sarin et al., 2005; Siegl-Cachedenier et al., 2007) .
Although these studies provide evidence that TERT has functions beyond maintaining telomere length, it remains unclear whether telomerase activity is required for its protective role against damaging agents and conditions. Deletion of either TERT or TERC completely eliminates telomerase activity (Blasco et al., 1997; Yuan et al., 1999) . However, suppression of TERT expression induces growth suppression and apoptosis prior to measurable telomere shortening (Folini et al., 2005) . Consistent with these observations, expression of specific TERT mutants that lack telomerase activity prevents apoptotic cell death (Cao et al., 2002; Rahman et al., 2005) , although one group reported that a TERT mutant lacking telomerase activity failed to protect cells against cytotoxic stresses including staurosporine (STS) and etoposide (Zhang et al., 2003) . Since the majority of these prior studies were performed in cells, here we have explored the contribution of telomerase activity to TERT-mediated cytoprotection from agents that induce cell stress using both cell lines and genetically engineered mice in which TERT and TERC components have been manipulated.
To confirm the protective activity of TERT, we transiently overexpressed a C-terminally hemagglutinin (HA)-tagged version of human TERT (hTERT-HA) in 293T cells. hTERT-HA shows telomerase activity in biochemical assays but fails to elongate or maintain telomeres when expressed in human cells (Counter et al., 1998) . Using cells expressing a control vector or HAhTERT, we measured the protective activity of TERT against STS, which induces apoptosis by translocating proapoptotic protein Bax into mitochondria and thus evoking the subsequent apoptotic cascade (Li et al., 2000; Wei et al., 2001) . We found that the transient overexpression of hTERT-HA significantly decreased STS-induced apoptosis of 293T cells, comparable to the protective effect observed using the X-linked inhibitor of apoptosis (XIAP; Deveraux et al., 1997;  Figure 1a ). Since caspase-3, the key mediator of apoptosis, is cleaved upon its activation (Lakhani et al., 2006) , we evaluated the effect of hTERT-HA overexpression on caspases-3 activation. Consistently, caspase-3 cleavage Telomerase activity-independent, TERT-mediated protection J Lee et al was rarely observed in 293T cells that overexpressed hTERT-HA upon STS treatment ( Figure 1b ). We also noted that cytochrome c release, a marker of mitochondrial membrane integrity disruption (Li et al., 2000) , was inhibited by hTERT-HA overexpression ( Figure 1c ). These observations suggest that TERT overexpression protects 293T cells from STS-induced apoptosis at the level of the mitochondria.
To extend these cell-based studies into a more physiological context, we next investigated the protective functions of TERT using genetically engineered mice lacking TERT (Yuan et al., 1999) . As a first step, we generated wild-type and first generation (G1) TERTdeficient mouse embryonic fibroblasts (MEFs) from intercrosses of TERT-heterozygous knockout mice and measured their susceptibility to STS treatment (Figure 2) . We observed 1.6-fold more apoptotic cells in G1 TERT-deficient MEFs than in wild-type MEFs upon STS treatment (Figure 2a ). Consistently, we also found increased Annexin V-positive cells in TERT-deficient MEF cultures than were observed in wild-type MEF cultures (Figure 2b ), using an Annexin V/propidium iodide (PI) double-staining assay (Seleznev et al., 2006) . Moreover, when we measured cytochrome c release, we found increased cytochrome c release in TERT-deficient MEFs as compared to wild-type MEFs (Figure 2c ). Since G1 TERT-deficient MEFs exhibit no significant telomere abnormalities (Erdmann et al., 2004) , these observations suggest that TERT regulates cell survival in response to stresses such as STS independently of telomere shortening. Indeed, when we generated G1 compound mice that harbor a TERT transgene (Kang et al., 2004) and lack TERC (Lee et al., 1998) , we found that deletion of TERC failed to alter the resistance of mTERT transgenic MEFs to STS treatment (Figure 2d ), even though telomerase activity was eliminated by the deficiency of TERC (Blasco et al., 1997) . Taken together, these observations indicate that telomerase activity is not required for TERT-mediated resistance to STS treatment.
Although TERT and TERC are evolutionarily conserved in humans and mice (Blasco et al., 1995; Greenberg et al., 1998) , the species-specific variations of TERT and TERC are critical for the proper role of telomerase in each species. For example, the ectopic expression of mTERT restores telomerase activity in normal human cells, but cannot elongate telomeres (Middleman et al., 2006) . Moreover, telomerase activity cannot be reconstituted with hTERT and mTERC in vitro even though mTERC efficiently binds to hTERT Telomerase activity-independent, TERT-mediated protection J Lee et al in vitro (Autexier et al., 1996; Beattie et al., 1998; Chen and Greider, 2003) . Furthermore, hTERT suppresses endogenous telomerase activity of murine cells expressing active telomerase as a dominant-negative manner (Boklan et al., 2002) . To confirm our findings in another experimental model, we tested whether hTERT exerts protective effects independently of its role in telomere maintenance by analysing a transgenic mouse line that ubiquitously expresses hTERT (Figure 3a) . Expression of hTERT was confirmed via western blot analyses using anti-hTERT-specific antibody (Wu et al., 2006 ; Figure 3b ; Supplementary Figure 1) . Consistent with prior studies, we found that endogenous telomerase activity was suppressed in hTERT transgenic MEFs (Figure 3c ). When hTERT transgenic MEFs were treated with STS, we found that they were less sensitive to STS exposure than wild-type MEFs (Figure 3d ). Consistent with these observations, we found that the transient expression of hTERT-HA in TERT-deficient MEFs induced resistance to STS-induced cell death (Figure 3e ). Taken together, these studies demonstrate that the antiapoptotic function of TERT is separable from its effects on telomere maintenance. We have previously shown that the transgenic overexpression of mTERT significantly attenuates excitotoxic neuronal cell death both in vivo and in vitro (Kang et al., 2004) . We further determined the protective effect of TERT on NMDA-induced lethality in TERT-deficient mice (Sofia et al., 1994) . When a lethal dose of NMDA was injected intraperitoneally, TERT-deficient mice were more susceptible than wildtype mice to NMDA-induced mortality (Figure 4a ). In addition, TERT-deficient primary neurons were more sensitive to NMDA than primary neurons derived from TERT þ /À mice ( Figure 4b ). Consistent with our prior studies, NMDA-induced mortality was considerably decreased in two independent mTERT transgenic mouse lines compared with wild-type mice (Figure 4c ). Therefore, TERT protects mice from NMDA-induced mortality through attenuating NMDA-induced excitotoxicity in vivo.
To confirm the neuroprotective effect of TERT in a different in vivo condition, we examined the rate of apoptotic cell death of motor neurons (MNs) induced by sciatic nerve axotomy (Sun et al., 2003) . After sciatic nerve axotomy, the survival rate of MNs derived from mTERT transgenic neonates (82.6 ± 4.6%) was significantly higher than that observed in wild-type neonates (63.5±5%; Figure 4e ). Taken together, these two independent lines of evidence indicate that TERT is physiologically critical for the organismal survival at stressful conditions.
To determine whether telomerase activity is necessary for protection from NMDA-induced excitotoxicity, we Telomerase activity-independent, TERT-mediated protection J Lee et al examined primary neurons derived from mTERT transgenic mice that are also TERC deficient. Notably, cultured neurons derived from TERT transgenic mice lacking TERC, lacking telomerase activity (Blasco et al., 1997) , showed a similar response to those derived from TERT transgenic mice (Figure 4d ). Therefore, TERT attenuates the NMDA-induced excitotoxicity even in the absence of telomerase activity. Taken together, these results show that the protective function of TERT is not associated with telomerase activity. Previous studies have suggested that telomerase confers an antiapoptotic function independent of its role in maintaining telomeres. The majority of these studies have used transformed cell lines, which has raised the possibility that these observations were nonphysiological. In these studies, we have used genetically engineered mice to study the role of TERT in protecting cells and animals from stress. Using these mouse models, the functions of telomerase associated with telomere elongation can be separated from its effects on apoptosis, and thus we can show that protective effect of TERT against stimuli that induce cell death is unrelated to its roles associated with maintaining the telomere length.
A prior report showed that mice lacking TERC show no difference to treatment with ionizing radiation (Wong et al., 2000) . Both TERC þ / þ and TERC À/À mice continue to express TERT, and thus our findings are consistent with these observations since we showed that deletion of TERC in the setting of TERT expression fails to alter susceptibility to NMDA treatment. Although our studies implicate full-length TERT as the mediator of the protective effects, it remains possible that these functions are also mediated by TERT alternative splice products. Seven alternative variants of TERT have been reported and are known to be expressed in many normal and cancer cells even though each of these alternative splicing forms of TERT lacks detectable telomerase activity (Yi et al., 2000) . Interestingly, the splicing patterns of TERT can be changed in keratinocytes during skin destruction and regeneration (Cerezo et al., 2002) . Therefore, it is possible that these splice variants with nonfunctional RT motifs exert protective functions or promote cellular and organismal survivals under stressful conditions in which the survival is more important than high rates of proliferation for tissue homeostasis (Lee et al., 1998 Telomerase activity-independent, TERT-mediated protection J Lee et al Several lines of evidence indicate that TERT may suppress the mitochondrial death pathway (Zhang et al., 2003; Massard et al., 2006) . The findings presented here are consistent with these observations. For example, TERT exhibits a protective activity against Bax-activating STS in both 293T cells and MEFs (Figures 1-3) . Furthermore, the death of neonatal MNs after axotomy is known to be mediated by Bax and subsequent mitochondrial apoptotic cascades (Deckwerth et al., 1996; Sun et al., 2003) . Consistent with these observations, Bcl-2 transgenic mice are resistant to the axotomy-induced cell death by inhibiting Bax translocation into mitochondria (Dubois-Dauphin et al., 1994) . Therefore, the significant reduction of axotomy-induced apoptosis in MNs of mTERT transgenic neonates (Figure 4e ) suggests that TERT may suppress the mitochondrial step of apoptosis in vivo. Similarly, NMDA is also known to elicit the Bax translocation into mitochondria (Djebaili et al., 2000; Perez-Navarro et al., 2005) . We showed that TERT suppresses NMDA-induced neuronal cell death both in vivo and in vitro (Figures 4a-d) . The overexpression of TERT enhances the basal level of Dc m and thus neutralizes the increase of Ca 2 þ in mitochondria (Kang et al., 2004) . Bcl-2 is also known to promote resistance to Ca 2 þ -induced respiratory injury by increasing the mitochondrial Ca 2 þ uptake (Murphy et al., 1996) . Taken together, these observations are consistent with a role for TERT in blocking mitochondrial pathway of apoptosis.
These studies suggest that telomerase plays at least two functions in mammalian cells, one involved in telomere maintenance and a second separable function involved in inhibiting apoptosis at the level of mitochondria. Since decreasing mitochondrial function is also believed to contribute to aging through generating reactive oxygen species (ROS), our results may link two major aging hypotheses, that is, the mitochondrial ROS hypothesis (Wallace, 2005) and the intrinsic telomere hypothesis (Collado et al., 2007; Finkel et al., 2007) . Further studies will be necessary for complete the picture of telomerase biology in both aging and cancer.
